Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic cancer research or clinical care. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Funding: $400,000 total 

Duration: 3 years 

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19

Full proposal due dates: 7.3.19, 28.5.19. 27.9.19